Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
34.2M
-
Shares change
-
-2.8M
-
Total reported value, excl. options
-
$238M
-
Value change
-
-$18.9M
-
Put/Call ratio
-
1.35
-
Number of buys
-
41
-
Number of sells
-
-43
-
Price
-
$6.96
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q4 2022
112 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2022.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.2M shares
of 60M outstanding shares and own 56.91% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11.4M shares), VANGUARD GROUP INC (2.49M shares), Knoll Capital Management, LLC (1.95M shares), EAGLE ASSET MANAGEMENT INC (1.77M shares), Verition Fund Management LLC (1.56M shares), BlackRock Inc. (972K shares), FMR LLC (966K shares), Laurion Capital Management LP (957K shares), DIMENSIONAL FUND ADVISORS LP (890K shares), and Prosight Management, LP (859K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.